Tom Taulli

Tom Taulli

InvestorPlace Contributor

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Why Bumble Stock Won’t Stumble

By Tom Taulli, InvestorPlace Contributor

The company has the potential to go well beyond dating.

Qualcomm Stock Is a Power Play on 5G and AI

By Tom Taulli, InvestorPlace Contributor

Qualcomm is nicely positioned, with a positive outlook, and the valuation of QCOM stock remains reasonable at this point.

Here’s What Makes Canopy Growth Stock a Solid, Long-Term Cannabis Play

By Tom Taulli, InvestorPlace Contributor

CGC stock looks stands out among the crowd.

Lofty Expectations Are Already Priced Into Bionano Genomics

By Tom Taulli, InvestorPlace Contributor

BNGO stock is on the high side right now, especially since it will likely take time for the company's system to get traction.

7 Ways the Government Could Modernize Stock Market Rules

By Tom Taulli, InvestorPlace Contributor

Now is a great time to think about some regulations. Thus, let's take a closer look at ways the government could modernize stock market rules.

7 of the Top Mutual Funds to Look for in Your 401k

By Tom Taulli, InvestorPlace Contributor

For many, it can be hard to know what to put in your 401k. Here’s a look at a diverse set of mutual funds to help improve returns.

It May Be Too Early to Believe in Zomedica Stock

By Tom Taulli, InvestorPlace Contributor

There are heavy expectations for ZOM stock, even though Zomedica still has no revenues and a measured plan to roll out its Truforma device.

5G Is Simply Not Enough for Nokia Stock

By Tom Taulli, InvestorPlace Contributor

The recent Reddit-inspired surge may be the last big, positive move for NOK stock for some time, as the company is facing multiple challenges.

Palantir: The Sell-Off Is Not Over

By Tom Taulli, InvestorPlace Contributor

PLTR has been hit hard -- which is the result of the general market bearishness and a disappointing earnings report.

Even After the Name Change, TransEnterix Lacks the Momentum It Needs

By Tom Taulli, InvestorPlace Contributor

TRXC stock has pulled off a nice rally. But the company’s systems could take some time to get traction.

Load More